PropertyValue
?:abstract
  • Patients with acute leukemia present with a prolonged and severe course of COVID-19, which is paralleled by high rates of viremia. Low-intensive chemotherapy seems to be more feasible in patients with acute myeloid leukemia and concomitant SARS-CoV-2 infection.
is ?:annotates of
?:creator
?:doi
  • 10.1182/bloodadvances.2020002543
?:doi
?:journal
  • Blood_Adv
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/8444658aa99bc7b98d72e378217a0dc6e7712293.json; document_parses/pdf_json/80c96810804ecb2bd2314f9b90c835b653e8fd36.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7724904.xml.json
?:pmcid
?:pmid
?:pmid
  • 33275765.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
?:type
?:year
  • 2020-12-04

Metadata

Anon_0  
expand all